1 March 2023 false No description of principal activity Taxfiler 2024.6 11841031business:PrivateLimitedCompanyLtd2023-03-012024-02-29 118410312023-02-28 118410312023-03-012024-02-29 11841031business:AuditExempt-NoAccountantsReport2023-03-012024-02-29 11841031business:AbridgedAccounts2023-03-012024-02-29 118410312024-02-29 118410312023-02-28 11841031core:WithinOneYear2024-02-29 11841031core:WithinOneYear2023-02-28 11841031core:AfterOneYear2024-02-29 11841031core:AfterOneYear2023-02-28 11841031core:ShareCapitalcore:PreviouslyStatedAmount2024-02-29 11841031core:ShareCapitalcore:PreviouslyStatedAmount2023-02-28 11841031core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-02-29 11841031core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-02-28 11841031core:PreviouslyStatedAmount2024-02-29 11841031core:PreviouslyStatedAmount2023-02-28 11841031business:SmallEntities2023-03-012024-02-29 11841031business:Director22023-03-012024-02-29 11841031countries:EnglandWales2023-03-012024-02-29 11841031business:RegisteredOffice2023-03-012024-02-29 11841031core:PlantMachinery2023-03-012024-02-29 118410312022-03-012023-02-28 iso4217:GBP xbrli:pure
Company Registration No. 11841031 (England and Wales)
SAVILLE PHARMACY LTD Unaudited accounts for the year ended 29 February 2024
SAVILLE PHARMACY LTD Unaudited accounts Contents
Page
- 2 -
SAVILLE PHARMACY LTD Statement of financial position as at 29 February 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Intangible assets
600,000 
600,000 
Tangible assets
72,000 
3,000 
672,000 
603,000 
Current assets
Inventories
41,048 
41,048 
Debtors
46,196 
76,714 
Cash at bank and in hand
29,230 
74,592 
116,474 
192,354 
Creditors: amounts falling due within one year
(81,680)
(81,200)
Net current assets
34,794 
111,154 
Total assets less current liabilities
706,794 
714,154 
Creditors: amounts falling due after more than one year
(570,025)
(568,469)
Net assets
136,769 
145,685 
Capital and reserves
Called up share capital
1 
1 
Profit and loss account
136,768 
145,684 
Shareholders' funds
136,769 
145,685 
For the year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the year in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 18 November 2024 and were signed on its behalf by
Lyakat Gulamhusein Jaffer Director Company Registration No. 11841031
- 3 -
SAVILLE PHARMACY LTD Notes to the Accounts for the year ended 29 February 2024
1
Statutory information
SAVILLE PHARMACY LTD is a private company, limited by shares, registered in England and Wales, registration number 11841031. The registered office is 111A HIGH STREET, WEALDSTONE, HARROW, MIDDLESEX, HA3 5DL.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
5 years straight line
Intangible fixed assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
4
Intangible fixed assets
Total 
£ 
Cost
At 1 March 2023
600,000 
At 29 February 2024
600,000 
Amortisation
At 1 March 2023
- 
At 29 February 2024
- 
Net book value
At 29 February 2024
600,000 
At 28 February 2023
600,000 
- 4 -
SAVILLE PHARMACY LTD Notes to the Accounts for the year ended 29 February 2024
5
Tangible fixed assets
Total 
£ 
Cost or valuation
At 1 March 2023
15,000 
Additions
80,000 
At 29 February 2024
95,000 
Depreciation
At 1 March 2023
12,000 
Charge for the year
11,000 
At 29 February 2024
23,000 
Net book value
At 29 February 2024
72,000 
At 28 February 2023
3,000 
6
Average number of employees
During the year the average number of employees was 10 (2023: 7).
- 5 -